参考文献/References:
［1］Siegel RL，Miller KD，Sauer A，et al.Colorectal cancer statistics，2020［J］.CA Cancer J Clin，2020，70：145-164.
［2］牛惠敏，王志恒，高石鑫，等.钇90放射性微球在肝脏恶性肿瘤中的应用及进展［J］.肝癌电子杂志，2021，8：36-40.
［3］郑致远.钇90放射性微球治疗肝脏恶性肿瘤的应用进展［J］.复旦学报（医学版），2020，47：622-627.
［4］高洁，刘晓明，周文华，等.90Y微球的研发现状与应用研究［J］.同位素，2022，35：189-199.
［5］Levillain H，Bagni O，Deroose CM，et al.International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres［J］.Eur J Nucl Med Mol Imaging，2021，48：1570-1584.
［6］Salem R，Gordon AC，Mouli S，et al.Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma［J］.Gastroenterology，2016，151：1155-1163.e2.
［7］Moslim MA，Jeyarajah DR.Narrative review of the role of yttrium-90 selective internal radiation therapy in the surgical management of colorectal liver metastases［J］.J Gastrointest Oncol，2021，12：2438-2446.
［8］Gray B，Van HG，Hope M，et al.Randomised trial of SIR-spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer［J］.Ann Oncol，2001，12：1711-1720.
［9］Bargellini I，Bozzi E，Lorenzoni G，et al.Role of transhepatic arterial radioembolization in metastatic colorectal cancer［J］.Cardiovasc Intervent Radiol，2022，45：1579-1589.
［10］Memeo R，Conticchio M，Deshayes E，et al.Optimization of the future remnant liver：review of the current strategies in Europe［J］.Hepatobiliary Surg Nutr，2021，10：350-363.
［11］Garlipp B，Gibbs P，Van Hazel GA，et al.Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial［J］.Br J Surg，2019，106：1837-1846.
［12］Birgin E，Rasbach E，Seyfried S，et al.Contralateral liver hypertrophy and oncological outcome following radioembolization with 90Y-Microspheres：a systematic review［J］.Cancers （Basel），2020，12：294.
［13］Ironside N，Bell R，Bartlett A，et al.Systematic review of perioperative and survival outcomes of liver resections with and without preoperative portal vein embolization for colorectal metastases［J］.HPB （Oxford），2017，19：559-566.
［14］王草叶，贾中芝，王维平.钇-90微球放射性肝段切除——钇-90微球放射栓塞系列回顾（九）［J］.介入放射学杂志，2018，27：1210-1216.
［15］Entezari P，Gabr A，Salem R，et al.Yttrium-90 for colorectal liver metastasis-the promising role of radiation segmentectomy as an alternative local cure［J］.Int J Hyperthermia，2022，39：620-626.
［16］Kurilova I，Bendet A，Fung EK，et al.Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres［J］.Abdom Radiol （NY），2021，46：3428-3436.
［17］Wasan HS，Gibbs P，Sharma NK，et al.First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer （FOXFIRE，SIRFLOX，and FOXFIRE-Global）：a combined analysis of three multicentre，randomised，phase Ⅲ trials［J］.Lancet Oncol，2017，18：1159-1171.
［18］Gibbs P，Heinemann V，Sharma NK，et al.Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy：combined analysis of two randomized controlled studies［J］.Clin Colorectal Cancer，2018，17：e617-e629.
［19］Van Cutsem E，Cervantes A，Adam R，et al.ESMO consensus guidelines for the management of patients with metastatic colorectal cancer［J］.Ann Oncol，2016，27：1386-1422.
［20］Mulcahy MF，Mahvash A，Pracht M，et al.Radioembolization with chemotherapy for colorectal liver metastases：a randomized，open-label，international，multicenter，phase Ⅲ trial［J］.J Clin Oncol，2021，39：3897-3907.
［21］Hendlisz A，Van den Eynde M，Peeters M，et al.Phase Ⅲ trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy［J］.J Clin Oncol，2010，28：3687-3694.
［22］Benson AB，Venook AP，Al-Hawary MM，et al.Colon cancer，version 2.2021，NCCN clinical practice guidelines in oncology［J］.J Natl Compr Canc Netw，2021，19：329-359.
［23］Helmberger T，Golfieri R，Pech M，et al.On behalf of the CIRT steering committee；On behalf of the CIRT principal investigators.Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe：first results from the prospective multicentre observational study CIRSE registry for SIR-spheres therapy （CIRT）［J］.Cardiovasc Intervent Radiol，2021，44：21-35.
［24］Sofocleous CT，Garcia AR，Pandit-Taskar N，et al.Phase Ⅰ trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy［J］.Clin Colorectal Cancer，2014，13：27-36.
［25］Walter T，Hawkins NS，Pollock RF，et al.Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer［J］.J Cancer Res Clin Oncol，2020，146：2575-2587.
［26］Kemeny NE，Melendez FD，Capanu M，et al.Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma［J］.J Clin Oncol，2009，27：3465-3471.
［27］Cercek A，Gendel V，Jabbour S，et al.A comparison of yttrium-90 microsphere radioembolization to hepatic arterial infusional chemotherapy for patients with chemo-refractory hepatic colorectal metastases［J］.Curr Treat Options Oncol，2017，18：42.
［28］Filippi L，Evangelista L，Schillaci O.Integrated use of 90Y-labeled microspheres and immune checkpoint inhibitors in hepatic tumors：current status and future directions［J］.Expert Rev Gastroenterol Hepatol，2023，17：531-538.
［29］Wang C，Park J，Ouyang C，et al.A pilot feasibility study of yttrium-90 liver radioembolization followed by durvalumab and tremelimumab in patients with microsatellite stable colorectal cancer liver metastases［J］.Oncologist，2020，25：382-e776.
相似文献/References:
[1]陈庆华.肝动脉栓塞微球对移植型肝癌大鼠疗效的实验研究[J].介入放射学杂志,1994,(02):93.
[2]罗剑钧,王建华,刘清欣,等.微球联合碘油栓塞治疗肝癌的初步经验[J].介入放射学杂志,2007,(03):162.
LUO Jian-jun,WANG Jian-hua,LIU Qing-xin,et al.Preliminary experience of HCC treated by embolization of microspheres combined with lipiodol[J].journal interventional radiology,2007,(01):162.
[3]瞿旭东,王建华,颜志平,等.介入导入三氧化二砷微球对 VX２ 兔肝肿瘤模型的治疗作用[J].介入放射学杂志,2007,(03):184.
QU Xu-dong,WANG Jian-hua,YAN Zhi-ping,et al.The treatment effect of As ２ O ３ -PLGA microspheres on VX２rabbits liver tumor models[J].journal interventional radiology,2007,(01):184.